Poland - Lublin: Pharmaceutical products

Release

ID (OCID): ocds-pyfy63:2021-213998
Releases: 2021-04-30 (ocds-pyfy63:2021-213998:2021-213998)
2021-07-09 (ocds-pyfy63:2021-213998:2021-345861)

Title: Poland - Lublin: Pharmaceutical products
Award criteria: ratedCriteria
Award criteria details: The most economic tender

Award criteria for item 1:
- Price (60)
- Quality: termin dostawy (40)

Award criteria for item 2:
- Price (60)
- Quality: termin dostawy (40)
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2021-07-09 - ?
Tenderers: Abbvie Sp. z o.o., ul. Postępu 21B, 02-676 Warszawa
Janssen-Cilag Polska sp. z o.o., ul. Iłżecka 24, 02-135 Warszawa

ID: ocds-pyfy63:2021-213998:obj:1
Classification: CPV / 33600000
Description: 1. Venetoclaxum 10 mg, op. 14 tabl. powl. 10 op.2. Venetoclaxum 100 mg, op. 112 tabl. powl. 120 op.3. Venetoclaxum 100 mg, op. 14 tabl. powl. 10 op.4. Venetoclaxum 100 mg, op. 7 tabl. powl. 10 op.5. Venetoclaxum 50 mg, op. 7 tabl. powl. 10 op.

Roles: supplier
tenderer
Organization name: Janssen-Cilag Polska sp. z o.o., ul. Iłżecka 24, 02-135 Warszawa
Locality: Warszawa
Country: PL